We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$187B
AUM Growth
-$1.41B
Cap. Flow
-$2.94B
Cap. Flow %
-1.58%
Top 10 Hldgs %
24.38%
Holding
10,185
New
1,269
Increased
3,519
Reduced
3,507
Closed
1,718

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$940M
2
GLD icon
SPDR Gold Trust
GLD
+$375M
3
C icon
Citigroup
C
+$202M
4
GILD icon
Gilead Sciences
GILD
+$150M
5
M icon
Macy's
M
+$81.3M

Sector Composition

Rank Sector Weight
1 Technology 1.75%
2 Financials 1.43%
3 Consumer Discretionary 0.87%
4 Healthcare 0.87%
5 Energy 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KGJI
8226
DELISTED
Kingold Jewelry Inc.
KGJI
$50K ﹤0.01%
+4,640
New +$42.1K
PXLW icon
8227
Pixelworks
PXLW
$41.2M
$49K ﹤0.01%
2,215
-99
-4% -$2.33K
PTX
8228
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$49K ﹤0.01%
10,842
+7,904
+269% +$51.6K
OREX
8229
DELISTED
Orexigen Therapeutics, Inc.
OREX
$49K ﹤0.01%
11,463
-18,939
-62% -$85.6K
EXTR icon
8230
CALL
Extreme Networks
EXTR
$2.98B
$48K ﹤0.01%
14,100
-9,700
-41% -$33.2K
VIRX
8231
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$48K ﹤0.01%
420
-11
-3% -$1.22K
ADVM
8232
PUT
DELISTED
Adverum Biotechnologies
ADVM
$47K ﹤0.01%
1,500
+130
+9% +$5.87K
HOV icon
8233
CALL
Hovnanian Enterprises
HOV
$752M
$47K ﹤0.01%
+1,124
New +$46.7K
VHI icon
8234
Valhi
VHI
$521M
$47K ﹤0.01%
+2,488
New +$54.6K
DMK
8235
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$47K ﹤0.01%
+241
New +$111K
HIL
8236
PUT
DELISTED
Hill International, Inc. Common Stock
HIL
$47K ﹤0.01%
+11,600
New +$47.4K
GV
8237
CALL
DELISTED
Goldfield Corporation
GV
$47K ﹤0.01%
+14,400
New +$36.2K
BWEN icon
8238
Broadwind
BWEN
$104M
$46K ﹤0.01%
+10,956
New +$40K
RHE
8239
PUT
DELISTED
Regional Health Properties, Inc.
RHE
$46K ﹤0.01%
2,092
+509
+32% +$12.9K
CARM
8240
DELISTED
Carisma Therapeutics
CARM
$45K ﹤0.01%
+1,333
New +$33.7K
ELSE
8241
DELISTED
Electro-Sensors
ELSE
$45K ﹤0.01%
+14,130
New +$47.3K
SOL
8242
DELISTED
Emeren Group
SOL
$45K ﹤0.01%
+7,219
New +$47.6K
XOMA
8243
PUT
DELISTED
Xoma
XOMA
$45K ﹤0.01%
4,065
-1,940
-32% -$27.8K
GV
8244
DELISTED
Goldfield Corporation
GV
$45K ﹤0.01%
13,865
-1,665
-11% -$4.19K
PGLC
8245
CALL
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
$45K ﹤0.01%
+10,500
New +$42.5K
ANY icon
8246
Sphere 3D
ANY
$21M
$44K ﹤0.01%
4
-1
-20% -$15.3K
DRRX
8247
DELISTED
DURECT Corp
DRRX
$44K ﹤0.01%
3,607
+2,224
+161% +$28.5K
ZIXI
8248
DELISTED
Zix Corporation
ZIXI
$44K ﹤0.01%
11,663
+175
+2% +$683
ARQL
8249
CALL
DELISTED
Arqule Inc
ARQL
$44K ﹤0.01%
23,200
+5,000
+27% +$8.47K
WAC
8250
CALL
DELISTED
Walter Investment Mgt Corp
WAC
$44K ﹤0.01%
15,800
-23,700
-60% -$128K

Similar funds

Jeff Yass's Q2 2016 Portfolio in Review

As of Q2 2016, Jeff Yass held 10,185 positions worth $187B, down 0.75% from $188B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q2 2016 filing shows 1,269 new, 3,519 increased, 3,507 reduced and 1,718 closed positions. Its largest new stake was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.28B.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jeff Yass's largest Q2 2016 buy was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M.
  • Jeff Yass added most to Apple in Q2 2016, an estimated $940M increase.
  • Jeff Yass's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.28B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ETF in Q2 2016, selling an estimated $700M.
  • Jeff Yass's ten largest holdings make up 24% of its $187B portfolio in Q2 2016.
  • Jeff Yass opened 1,269 new positions and closed 1,718 in Q2 2016.
  • Jeff Yass's portfolio value fell 0.75% quarter-over-quarter to $187B.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.